TNB-383B

· AbbVie

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TNB-383B, covering 2026-02-06 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]